Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Western Sydney Local Health District has 4 pending office actions in Biotechnology & Pharmaceuticals. Those matters involve 4 distinct examiners and 4 distinct art units, so the portfolio’s prosecution activity is distributed across separate examination channels.
MOORE, JOHN DAVID is the busiest examiner, with 1 pending office action. Because the listed matters are spread across examiners and art units, prosecution planning should account for varied examination approaches rather than rely on a single recurring pattern.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (25%) |
| §101 + other | 1 (25%) |
| §103 only | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MOORE, JOHN DAVID | 1 | 61.1% | +28.3% |
| MURPHY, VICTORIA | 1 | 62.0% | +46.3% |
| MONTANARI, DAVID A | 1 | 64.8% | +49.0% |
| GUERRERO ROSARIO, ANA VERUSKA | 1 | 45.2% | +46.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18033760 | MODULATING INSULIN EXPRESSION AND PRODUCTION BY TARGETING CD47 | MONTANARI, DAVID A | 71d |
| 18713389 | PROBIOTIC PLASMIDS AND USE OF SAME | MOORE, JOHN DAVID | — |
| 18551022 | VENTILATION ASSISTANCE | MURPHY, VICTORIA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17468420 | METHOD AND SYSTEM FOR MONITORING TISSUE ABLATION THROUGH CONSTRAINED IMPEDANCE MEASUREMENTS | GUERRERO ROSARIO, ANA VERUSKA | 39d |
| 18033760 | MODULATING INSULIN EXPRESSION AND PRODUCTION BY TARGETING CD47 | MONTANARI, DAVID A | 71d |
| 18713389 | PROBIOTIC PLASMIDS AND USE OF SAME | MOORE, JOHN DAVID | — |
| 18551022 | VENTILATION ASSISTANCE | MURPHY, VICTORIA | — |
| Art Unit | Apps |
|---|---|
| 1638 | 1 |
| 3785 | 1 |
| 1632 | 1 |
| 3794 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18713389 | PROBIOTIC PLASMIDS AND USE OF SAME | MOORE, JOHN DAVID | 1638 | §103§112 | Non-Final OA | — | Pending | May 24, 2024 |
| 18551022 | VENTILATION ASSISTANCE | MURPHY, VICTORIA | 3785 | §101 | Non-Final OA | — | Pending | Sep 18, 2023 |
| 18033760 | MODULATING INSULIN EXPRESSION AND PRODUCTION BY TARGETING CD47 | MONTANARI, DAVID A | 1632 | §101§102§112 | Non-Final OA | 71d | Pending | Apr 25, 2023 |
| 17468420 | METHOD AND SYSTEM FOR MONITORING TISSUE ABLATION THROUGH CONSTRAINED IMPEDANCE MEASUREMENTS | GUERRERO ROSARIO, ANA VERUSKA | 3794 | §103 | Final Rejection | 39d | Pending | Sep 07, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialWestern Sydney Local Health District has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
John David Moore has the most, with 1 of Western Sydney Local Health District's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
